Characteristics of children with positive tuberculin skin test

Arzu Babayiğit Hocaoğlu1, Duygu Olmez Erge, Ozden Anal

  • 1Department of Children Health and Diseases, Division of Children Allergy, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey. arbabayigit@yahoo.com

Tuberkuloz Ve Toraks
|July 12, 2011
PubMed

Insights

Childhood latent tuberculosis diagnosis is complicated by factors like age and BCG vaccination history affecting tuberculin skin test (TST) results. Newer in vitro tests may offer improved accuracy despite higher costs.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Latent tuberculosis infection (LTBI) diagnosis in children presents challenges.
  • The tuberculin skin test (TST) is a common diagnostic tool, but its interpretation can be affected by various factors.
  • Identifying risk factors for positive TST in pediatric populations is crucial for accurate diagnosis and treatment.

Purpose of the Study:

  • To characterize children diagnosed with latent tuberculosis infection using a positive TST.
  • To evaluate potential risk factors influencing TST results in children.
  • To assess the impact of demographic and clinical factors on TST reactivity in pediatric LTBI.

Main Methods:

  • Retrospective study evaluating 81 children with positive TST.
  • Data collection included patient demographics, medical history (atopy, respiratory infections, family history of TB/atopy), BCG vaccination status, and physical examination findings.
  • Statistical analysis focused on factors affecting TST reaction size.

Main Results:

  • Patient age, number of BCG vaccination scars, and BCG vaccination status significantly influenced TST reaction size.
  • Factors such as time since last BCG, family history of TB, household contact with TB cases, smoking exposure, household size, and allergic respiratory disease did not significantly affect TST size.
  • Only 16% of children with positive TST had known contact with an active TB case.

Conclusions:

  • Pediatric TST results are significantly affected by patient age and BCG vaccination history (scars and vaccination status).
  • These factors can complicate the diagnosis of LTBI and the decision to initiate prophylactic treatment in children.
  • The study suggests that newer, more accurate in vitro tests, despite higher costs and laboratory requirements, may be valuable for diagnosing pediatric LTBI.

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...